Page last updated: 2024-11-02

pifithrin and Experimental Neoplasms

pifithrin has been researched along with Experimental Neoplasms in 2 studies

pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source

Research Excerpts

ExcerptRelevanceReference
"Pancreatic cancer is an exceedingly lethal disease with a five-year survival that ranks among the lowest of gastrointestinal malignancies."1.38Evidence for activation of mutated p53 by apigenin in human pancreatic cancer. ( Chen, M; Eibl, G; Go, VL; Hines, OJ; King, JC; Li, G; Lu, QY; Moro, A; Reber, HA; Takahashi, H, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
King, JC1
Lu, QY1
Li, G1
Moro, A1
Takahashi, H1
Chen, M1
Go, VL1
Reber, HA1
Eibl, G1
Hines, OJ1
Stadler, P1
Grosu, AL1
Molls, M1

Other Studies

2 other studies available for pifithrin and Experimental Neoplasms

ArticleYear
Evidence for activation of mutated p53 by apigenin in human pancreatic cancer.
    Biochimica et biophysica acta, 2012, Volume: 1823, Issue:2

    Topics: Animals; Apigenin; Apoptosis; Apoptosis Regulatory Proteins; bcl-X Protein; Benzothiazoles; Cell Lin

2012
[A chemical inhibitor of p53 that protects mice from the side effects of cancer treatment].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2000, Volume: 176, Issue:2

    Topics: Animals; Antineoplastic Agents; Benzothiazoles; Combined Modality Therapy; Drug Evaluation, Preclini

2000